Pancreatic cancer
Results
Phase 2
This trial looked at a higher dose of radiotherapy and a drug called nelfinavir for pancreatic cancer. It was for people whose cancer couldn’t be removed with surgery. But it hadn’t spread to another part of the body.
The trial was supported by Cancer Research UK. It was open for people to join between 2016 and 2020. The research team presented the results at a conference in 2022.
Recruitment start: 8 March 2016
Recruitment end: 27 April 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Somnath Mukherjee
Cancer Research UK
Celgene Ltd
Experimental Cancer Medicine Centre (ECMC)
National Radiotherapy Trials Quality Assurance Group (RTTQA)
NIHR Clinical Research Network: Cancer
Oxford Clinical Trials and Research Unit (OCTRU)
University of Oxford
This is Cancer Research UK trial number CRUK/07/040.
Last reviewed: 7 September 2023
CRUK internal database number: 10078
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
